- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
VRTX
MEX
Week ended 24 Jul 2026
Weekly Investor Report
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
Latest close
8,192 MXN
-1.5%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.6% above the Trend Line and sits at 66.6% of its 52-week range. The latest completed week returned -1.5%, after a -5.5% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
46
out of 100
Latest Close
8,192 MXN
24 Jul 2026
1W Return
-1.5%
latest completed week
4W Return
-5.5%
short-term follow-through
12W Return
9.2%
quarterly tape
Trend Breadth
21.2%
11 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.5%
Latest completed week; four-week move -5.5%.
Indicator stack
15/97
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
33 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.6% above the Trend Line and sits at 66.6% of its 52-week range. The latest completed week returned -1.5%, after a -5.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3512-week average 0.24
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.35Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.5% over four weeks, 9.2% over 12 weeks, and -7.1% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year11
Trend breadth21.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.98Latest activity-pressure read.
Pressure change371.6%Four-week change in activity pressure.
Leadership2.13Latest relative-leadership reading.
RS change-57.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 33 relevant articles.
9 positive · 22 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.8%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher12 of 2612 weeks finished lower.
Best week+11.2%Week of 26 Jun.
Worst week-4.4%Week of 10 Apr.
Latest week-1.5%Week of 24 Jul.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks2
Modest losses11
Sharp losses1
Recent vol4.1%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split22/24Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank69 / 78
Group average0.9%
Trend breadth26.9%
Trend26.9%active weekly trend signals
MD61.5%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryMX Biotechnology
4-week rank12 / 19
Group average-2.7%
Trend breadth21.1%
Trend21.1%active weekly trend signals
MD52.6%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 1/12, activity pressure 4/12, relative leadership 5/12.
Activity pressure 0.35; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 33 relevant articles.
Is Vertex Pharmaceuticals (VRTX) Cheap On Its AbCellera Collaboration News? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 8,192 MXN | -1.5% | 7,987 MXN | 8,019 MXN | 0.98 | 2.13 | 39 | On |
| 17 Jul 2026 | 8,319 MXN | -2.5% | 7,989 MXN | 8,006 MXN | 1.11 | 2.82 | 87 | Off |
| 10 Jul 2026 | 8,530 MXN | -2.9% | 7,976 MXN | 7,992 MXN | 0.81 | 5.11 | 2.0K | Off |
| 3 Jul 2026 | 8,784 MXN | 1.3% | 7,956 MXN | 7,975 MXN | 0.23 | 6.86 | 20 | Off |
| 26 Jun 2026 | 8,670 MXN | 11.2% | 7,939 MXN | 7,956 MXN | -0.36 | 5.01 | 367 | Off |
| 19 Jun 2026 | 7,795 MXN | 2.7% | 7,917 MXN | 7,939 MXN | -0.84 | -6.51 | 0 | Off |
| 12 Jun 2026 | 7,592 MXN | 2.2% | 7,925 MXN | 7,927 MXN | -0.95 | -9.75 | 0 | Off |
| 5 Jun 2026 | 7,426 MXN | -3.6% | 7,942 MXN | 7,917 MXN | -0.94 | -9.83 | 0 | Off |
| 29 May 2026 | 7,700 MXN | 2.2% | 7,953 MXN | 7,905 MXN | -0.98 | -10.37 | 53 | Off |
| 22 May 2026 | 7,535 MXN | -3.0% | 7,956 MXN | 7,892 MXN | -1.08 | -12.50 | 1.1K | Off |
| 15 May 2026 | 7,770 MXN | 6.0% | 7,965 MXN | 7,881 MXN | -1.14 | -9.75 | 25 | Off |
| 8 May 2026 | 7,333 MXN | -2.2% | 7,957 MXN | 7,870 MXN | -1.13 | -17.52 | 47 | Off |
| 1 May 2026 | 7,501 MXN | -1.4% | 7,967 MXN | 7,862 MXN | -1.05 | -13.70 | 119 | Off |
| 24 Apr 2026 | 7,610 MXN | 0.1% | 7,965 MXN | 7,854 MXN | -0.86 | -14.91 | 22 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.